[Antituberculosis vaccination with B.C.G. I. Theoretical basis. Mechanism of B.C.G. vaccination and some of its practical aspects].
D000917:Antibody Formation; D001500:BCG Vaccine / Q000009:adverse effects; D002277:Carcinoma / Q000209:etiology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007231:Infant, Newborn; D007627:Keloid / Q000209:etiology; D008177:Lupus Vulgaris / Q000209:etiology; D008198:Lymph Nodes / Q000276:immunology; D008199:Lymphadenitis / Q000209:etiology; D008214:Lymphocytes / Q000276:immunology; D012157:Mononuclear Phagocyte System / Q000276:immunology; D010000:Osteitis / Q000209:etiology; D010587:Phagocytosis; D014374:Tuberculin Test; D014376:Tuberculosis / Q000517:prevention & control*
D001500:BCG Vaccine
La vaccinazione antitubercolare con B.C.G. I. Basi teoriche - meccanismo della vaccinazione con B.C.G. ed alcuni suoi aspetti pratici.